Skip to content

Study on the Efficacy and Safety of High-Energy Semi-Liquid Solid Beverages in Patients Undergoing Day Surgery

Study on the Efficacy and Safety of High-Energy Semi-Liquid Solid Beverages in Patients Undergoing Day Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120463
Enrollment
Unknown
Registered
2026-03-16
Start date
2026-03-17
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

CHO Group:Oral intake of carbohydrate solution
HSBBS Group:Oral intake of high?energy semi?liquid solid beverage (HESSB)

Sponsors

Obstetris & Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for day surgery hysteroscopy; 2. Age 18-60 years old; 3. ASA classification ? or ?; 4. BMI 18-30 kg/m^2; 5. Patients and their families have given informed consent and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.complicated with diabetes mellitus or other severe metabolic diseases; 2.presence of diseases causing delayed gastric emptying (e.g., gastroesophageal reflux disease, gastrointestinal obstruction, active gastric ulcer, etc.); 3.history of previous abdominal surgery, especially gastrointestinal surgery; 4.hypersensitivity to the ingredients of the study rice flour beverage or carbohydrate solution; 5.pregnancy or lactation; 6.expected operative duration exceeding 60 minutes; 7.administration of drugs affecting gastrointestinal motility or blood glucose metabolism within 24 hours preoperatively; 8.psychiatric disorders or cognitive dysfunction that prevent the patient from understanding and cooperating with the assessment measurements and questionnaires.

Design outcomes

Primary

MeasureTime frame
Comprehensive preoperative discomfort score;

Secondary

MeasureTime frame
Incidence of adverse reactions;Discharge time;PACU stay time;Grip strength level at discharge;Preoperative grip strength level;

Countries

China

Contacts

Public ContactYang Chen

Obstetris & Gynecology Hospital of Fudan University

annie.114@163.com+86 21 56319900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026